Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy [Phase 1, Phase 2]
A Phase 1/2 study evaluating the feasibility of high-dose accelerated conformal radiotherapy for non-small cell lung cancer; the trial has c…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy [Phase 3]
A Phase 3 clinical trial investigates whether adding celecoxib to chemotherapy improves survival in patients with advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC [Phase 2]
Phase II study evaluating celecoxib with concurrent radiotherapy in stage II-III Non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of gefitinib (Iressa) for brain metastases from non-small cell lung cancer was terminated. The study was sponsored by AstraZ…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation [Phase 3]
A Phase 3 trial evaluating FDG-PET-CT scans to predict outcomes in lung cancer patients receiving concurrent chemoradiation has been termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. [Phase 1]
Phase 1 safety study evaluating individualized radiation dose determination for non-small cell lung cancer patients; the trial has completed…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Phase II Study of ZD6474 in Advanced NSCLC [Phase 2]
Phase II study of vandetanib (ZD6474) in advanced non-small cell lung cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-06-22Clinical Trial Update: Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients [Phase 2]
This update covers the Phase 2 evaluation of BAY 59-8862 in taxane-resistant non-small cell lung cancer, noting that the trial has been comp…
-
CLINICAL_TRIALS research · 2009-06-18Clinical Trial Update: Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer [Phase 2]
This Clinical Trials update reports a Phase 2 study evaluating pemetrexed plus oxaliplatin as adjuvant chemotherapy after surgical resection…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 feasibility trial evaluating pemetrexed in combination with cisplatin or carboplatin as adjuvant therapy for non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer [Phase 2]
The document summarizes Phase 2 trial results assessing the safety and efficacy of S-8184 as second-line treatment for relapsed stage IIIB/I…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant pemetrexed and cisplatin before surgery in Non-Small-Cell Lung Cancer was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2009-06-01Clinical Trial Update: A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) [Phase 1]
A Phase 1 trial evaluated carboplatin plus paclitaxel with MK-0683 in chemotherapy-naive non-small cell lung cancer; the study was terminate…
-
CLINICAL_TRIALS research · 2009-05-25Clinical Trial Update: Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen [Phase 2]
This document provides a Phase 2 trial update on the combination of erlotinib and docetaxel in patients with locally advanced or metastatic …
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
Phase 2 study evaluating biweekly gemcitabine and docetaxel as first-line therapy for advanced non-small cell lung cancer in elderly patient…
-
CLINICAL_TRIALS research · 2009-05-21Clinical Trial Update: Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
A Phase 2 clinical trial update investigating biweekly gemcitabine and docetaxel as first-line therapy for advanced non-small cell lung canc…
-
CLINICAL_TRIALS research · 2009-05-19Clinical Trial Update: PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)
A clinical trial update describing the pharmacoeconomic assessment of IRESSA (gefitinib) for Non-Small Cell Lung Cancer.
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy followed by pulsed docetaxel with concurrent radiation for non-small cell lung cancer; the study statu…
-
CLINICAL_TRIALS research · 2009-05-18Clinical Trial Update: Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma [NA]
This clinical trial update describes a study investigating EGFR mutation–guided second-line therapy for patients with advanced lung adenocar…
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial compared pemetrexed plus gemcitabine on 14-day vs 21-day schedules in advanced non-small-cell lung cancer. The study was ter…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Phase II Iressa Versus Vinorelbine (INVITE) [Phase 2]
Phase II randomized trial INVITE comparing Iressa (gefitinib) to vinorelbine in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study [Phase 3]
Phase 3 trial comparing Iressa (gefitinib) with best supportive care in second/third-line non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2009-04-22Clinical Trial Update: Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating the use of nitroglycerin alongside chemotherapy and radiotherapy in patients with …
-
CLINICAL_TRIALS trial_result · 2009-04-16Clinical Trial Update: Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 randomized study comparing GEMOX (gemcitabine/oxaliplatin) to CP (carboplatin/paclitaxel) in non-small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating pemetrexed with cisplatin and radiotherapy for unresectable locally advanced non-small cell lung cancer has complet…